FdaApplication

NDA 021001

Back to search

Identifiers

Properties

PropertyValue
applicant_nameJANSSEN PHARMACEUTICALS INC
application_typeNDA
approval_date2001-05-07

Products (2)

ProductActive ingredientStrengthDosage form
AXERTALMOTRIPTAN MALATEEQ 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL
AXERTALMOTRIPTAN MALATEEQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL

2 products